Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00760994 · ClinicalTrials.gov registry record · NA

Reducing Alcohol Use & Post-traumatic Stress Disorder (PTSD) With Cognitive Restructuring & Experiential Acceptance

A NA study, sponsored by Seattle Institute for Biomedical and Clinical Research.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT00760994: Completed NA study, sponsored by Seattle Institute for Biomedical and Clinical Research.

NCT00760994 is a NA study that has completed, run by Seattle Institute for Biomedical and Clinical Research. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00760994, a NA study, has completed, sponsored by Seattle Institute for Biomedical and Clinical Research.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether an experiential acceptance therapy intervention is effective in the treatment of alcohol dependency and post-traumatic stress disorder (PTSD) symptoms in individuals who suffer from PTSD.

Primary Outcome

After the treatment had been started and for five weeks following the treatment, participants reported their alcohol use on the previous day using the IVR technology. Each participant's data were added and averaged to get the average drinks per day of each treatment group (EA and CR) and control group. The higher the number, the more drinks were consumed per day. Possible minimum value: 0. Possible maximum value: unlimited.

Interventions

  • BEHAVIORAL Cognitive restructuring
  • BEHAVIORAL Experiential acceptance
  • OTHER No-intervention control: Nutrition information

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2009-01
Est. Completion 2012-08
Phase NA

What the finished NCT00760994 record still lists

NCT00760994 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 3 interventions - of which Cognitive restructuring is the first listed.

NCT00760994 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00760994 about?

NCT00760994 is a clinical study titled "Reducing Alcohol Use & Post-traumatic Stress Disorder (PTSD) With Cognitive Restructuring & Experiential Acceptance". The purpose of this study is to determine whether an experiential acceptance therapy intervention is effective in the treatment of alcohol dependency and post-traumatic stress disorder (PTSD) symptoms in individuals who suffer from PTSD.

What is the current status of trial NCT00760994?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2009-01. Estimated completion is 2012-08.

What interventions are being tested in trial NCT00760994?

The interventions under investigation include: Cognitive restructuring (BEHAVIORAL), Experiential acceptance (BEHAVIORAL), No-intervention control: Nutrition information (OTHER).

Who is sponsoring clinical trial NCT00760994?

This trial is sponsored by Seattle Institute for Biomedical and Clinical Research, which has 43 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00760994's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00760994, the US trial registry maintained by the National Library of Medicine. NCT00760994 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.